期刊文献+

HCV准种复杂性与干扰素疗效关系的初步探讨 被引量:2

Relationship between HCV quasispecies complexity and response to interferon therapy
暂未订购
导出
摘要 目的 探讨丙型肝炎病毒 (HCV) 1b型患者HVR1 ,NS5A区准种复杂性与干扰素疗效的关系。方法 应用单链构象多态性聚合酶链反应 (SSCP)法检测慢性丙型肝炎患者干扰素治疗前后HCV准种的动态变化。结果 治疗前HCVHVR1准种的SSCP条带数 (复杂性 )≤ 3者在经干扰素治疗后HCVRNA阴转率为 71 .4 3% ,>3者HCVRNA阴转率为 1 5 .38% ,两者相比 ,差异有显著性 (P <0 .0 5 ) ;治疗有效组SSCP条带数为 2 .4 3± 0 .98( x±s) ,无效组为 4 .4 6± 0 .88,两者相比 ,差异亦具显著性 (P <0 .0 1 )。而NS5A区SSCP条带数则无差异。结论 HCV1b型慢性丙型肝炎患者HVR1区准种的复杂性与干扰素疗效有关 ;而NS5A区准种的复杂性与干扰素疗效无关。 Objective To investigate the relationship of HCV HVR1 and NS5A quasispecies complexity and the response to interferon (IFN) therapy in patients with HCV 1b infection. Methods Dynamic changes of HCV quasispecies before and after IFN therapy were detected using the method of polymerase chain reaction mediated single strand conformation polymorphism (PCR SSCP). Results After patients reveived IFN treatment, HCV RNA negative transformation rates in SSCP bands of HCV HVR1 ≤3 and >3 (detected prior to IFN treatment) were 71.43% and 15.38% , respectively, there was significant difference between them. The number of SSCP bands was 2.43 ± 0.98 (±s) and 4.46 ± 0.88 (±s) in effective patients group and ineffective patients group respectively, there was also significant difference between them, but there was no difference in SSCP bands of NS5A quasispecies. Conclusion The complexity of HCV HVR1 quasispecies was related with the curative effect of IFN therapy in patients with chronic hepatitis C and there was no correlation between the complexity of NS5A quasispecies and the curative effect of IFN therapy.
出处 《中国感染控制杂志》 CAS 2004年第2期103-105,共3页 Chinese Journal of Infection Control
关键词 HCV 丙型肝炎病毒 干扰素 准种复杂性 治疗 hepatitis C, chronic gene therapeutics interferon
  • 相关文献

参考文献8

  • 1[1]Sakai A, Kaneko S, Honda M, et al. Quasispecies of hepatitis C virus in serum and three different parts of the liver of patients with chronic hepatitis[J]. Hepatology, 1999, 30(2): 556-561.
  • 2[2]Koizumi K, Enomoto N, Kurosaki M, et al. Diversity of quasispecies in various disease stages of chronic hepatitis C virus infection and its significance in interferon treatment [J]. Hepatology, 1995, 22(1): 30-35.
  • 3[3]Moribe T, Hayashi N, Kanazawa Y, et al. Hepatitis C viral complexity detected by single-strand conformation polymorphism and response to interferon therapy[J]. Gastroenterology, 1995, 108(3): 789-795.
  • 4[4]Guen B L, Squadrito G, Nalpas B, et al. Hepatitis C virus genome complexity correlates with respons to interferon therapy: a study in French patients with chronic hepatitis C[J]. Hepatology, 1997, 25(5): 1250-1254.
  • 5[5]Enomoto N, Sakuma I, Asahina Y. Mutations in the nonstructural protein 5A gene and response to interferon in patients with chronic hepatitis C 1b infection[J]. N Eng J Med, 1996, 334(1): 77-81.
  • 6毕胜利,白宪鹤,丛勉尔,田厚文,孙得贵,H.S.Margolis,刘崇柏.中国人丙型肝炎病毒基因组的一级结构及其变异[J].病毒学报,1993,9(2):114-127. 被引量:73
  • 7[7]Polyak S J, Faulkner G, Carithers R L, et al. Assessment of hepatitis C virus quasispecies heterogeneity by gel shift analysis: correlation with response to interferon therapy[J]. J Infect Dis, 1997, 175(5): 1101-1107.
  • 8[8]Sandres K, Dubois M, Pasquier C, et al. Genetic heterogeneity of hypervariable region 1 of the hepatitis C virus (HCV) genome and sensitivity of HCV to alpha interferon therapy[J]. J Virol, 2000, 74(2): 661-668.

二级参考文献4

共引文献72

同被引文献10

引证文献2

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部